KP Tissue Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	560.06	-	-	-	-	-
Cost of Revenue	451.9	-	-	-	-	-
Gross Profit	108.15	-	-	-	-	-
Selling, General & Admin	55.29	-	-	-	-	-
Other Operating Expenses	0.05	-	-	-	-	-
Total Operating Expenses	55.34	0	0	0	0	0
Operating Income	52.81	-	-	-	-	-
Interest Income	18.2	17.24	4.86	-2.56	-	0.8
Interest Expense	-23.02	-	-	-	-	-
Other Non-Operating Income (Expense)	-3.47	1.53	1.74	2.2	-15.42	0.32
Total Non-Operating Income (Expense)	-8.29	18.76	6.61	-0.36	-15.42	1.12
Pretax Income	44.52	8.5	2.49	-0.83	-12.55	1.12
Provision for Income Taxes	8.31	-	0.11	4.11	-2.3	-0.12
Net Income	36.21	8.5	2.38	-4.94	-10.25	1.24
Net Income to Common	8.94	8.5	2.43	-4.94	-10.25	1.24
Net Income Growth	193.08%	249.53%	-	-	-	-
Shares Outstanding (Basic)	10	10	10	10	10	10
Shares Outstanding (Diluted)	10	10	10	10	10	10
Shares Change (YoY)	0.28%	0.27%	0.21%	0.20%	1.02%	1.36%
EPS (Basic)	0.89	0.85	0.24	-0.50	-1.03	0.13
EPS (Diluted)	0.89	0.85	0.24	-0.50	-1.03	0.13
EPS Growth	196.67%	254.17%	-	-	-	-
Free Cash Flow	191.6	-8.5	-2.43	4.94	10.25	-1.24
Free Cash Flow Growth	-	-	-	-51.83%	-	-
Free Cash Flow Per Share	19.14	-0.85	-0.24	0.50	1.03	-0.13
Dividends Per Share	0.720	0.720	0.720	0.720	0.720	0.720
Gross Margin	19.31%	-	-	-	-	-
Operating Margin	9.43%	-	-	-	-	-
Profit Margin	6.47%	-	-	-	-	-
FCF Margin	34.21%	-	-	-	-	-
EBITDA	116.63	0	0	0	0	0
EBITDA Margin	20.82%	-	-	-	-	-
EBIT	52.81	-	-	-	-	-
EBIT Margin	9.43%	-	-	-	-	-
Effective Tax Rate	18.67%	0.00%	4.50%	-494.82%	18.32%	-10.53%